Cerebrovascular diseases in ADHD patients with metabolic comorbidities: a retrospective cohort study
Sarah Krieg1, Andreas Krieg2, Karel Kostev3,4
1University Clinic for People with Neurodevelopmental Disorders, Mara Hospital, Medical School and University Medical Center OWL, Bielefeld University, Bielefeld, 33617, Germany. sarah.krieg@mara.de.
BMC Psychiatry
|August 21, 2025
Abstract
No abstract available in PubMed .
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
289
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
289
Hypertension III: Clinical Manifestations and Diagnostic Studies
48
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48


